Production (Stage)
Mineralys Therapeutics, Inc.
MLYS
$16.12
$0.503.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 343.03M | 198.19M | 263.60M | 311.12M | 338.57M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.48M | 7.16M | 4.13M | 6.89M | 8.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 354.51M | 205.35M | 267.73M | 318.00M | 346.82M |
|
|
|||||
| Total Current Assets | 354.51M | 205.35M | 267.73M | 318.00M | 346.82M |
| Net Property, Plant & Equipment | 38.00K | 53.00K | 69.00K | 42.00K | 51.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 397.00K | 499.00K | 452.00K | 449.00K | 379.00K |
| Total Assets | 354.94M | 205.90M | 268.25M | 318.49M | 347.25M |
|
|
|||||
| Total Accounts Payable | 373.00K | 479.00K | 3.11M | 1.71M | 4.26M |
| Total Accrued Expenses | 13.01M | 14.17M | 28.22M | 26.69M | 14.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.39M | 14.65M | 31.32M | 28.40M | 19.20M |
|
|
|||||
| Total Current Liabilities | 13.39M | 14.65M | 31.32M | 28.40M | 19.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.39M | 14.65M | 31.32M | 28.40M | 19.20M |
|
|
|||||
| Common Stock & APIC | 686.28M | 493.78M | 490.50M | 487.33M | 484.26M |
| Retained Earnings | -344.73M | -302.52M | -253.57M | -197.23M | -156.22M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 341.56M | 191.26M | 236.93M | 290.10M | 328.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 341.56M | 191.26M | 236.93M | 290.10M | 328.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 341.56M | 191.26M | 236.93M | 290.10M | 328.05M |
|
|
|||||